Login
$JHX
$26.32 +$0.30 (1.15%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Mar 31, 2012
Q4 FY2011
As of Mar 31, 2011
Assets
Current assets:
Cash and cash equivalents
Restricted cash and cash equivalents - Asbestos
Restricted cash and cash equivalents
Restricted short-term investments — Asbestos
Accounts and other receivables, net
Inventories
Prepaid expenses and other current assets
Assets held for sale
Insurance receivable - Asbestos
Workers’ compensation - Asbestos
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets
Finance lease right-of-use assets
Goodwill
Intangible assets, net
Restricted long-term investments - Asbestos
Insurance receivable - Asbestos
Workers’ compensation - Asbestos
Deferred income taxes
Deferred income taxes — Asbestos
Other assets
Total assets
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities
Accrued payroll and employee benefits
Operating lease liabilities
Finance lease liabilities
Long-term debt, current portion
Accrued product warranties
Income taxes payable
Asbestos liability
Workers’ compensation - Asbestos
Other liabilities
Total current liabilities
Long-term debt
Deferred income taxes
Operating lease liabilities
Finance lease liabilities
Accrued product warranties
Income taxes payable
Asbestos liability
Workers’ compensation - Asbestos
Other liabilities
Total liabilities
Shareholders’ equity:
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 580,354,409 shares issued and outstanding at June 30, 2026 and 580,174,308 shares issued and outstanding at March 31, 2026
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support